Expression profile of extracellular matrix and its regulatory proteins during the process of interstitial fibrosis after anti-glomerular basement membrane antibody-induced glomerular sclerosis in Sprague-Dawley rats

Pathology International

Volumn 49, Issue 8, 1999, Pages 716-725

  Adhikary, Laxman P ^a   Yamamoto, Tadashi ^a   Isome, Masato ^a   Nakano, Yoshimasa ^b   Kawasaki, Katsutoshi ^a   Yaoita, Eishin ^a   Kihara, Itaru ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anti GBM nephritis; Extracellular matrix; mRNA; TGF

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; GELATINASE A; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MESSENGER RNA; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RIBONUCLEASE PROTECTION ASSAY;

ANIMALS; ANTIBODIES; BASEMENT MEMBRANE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY CORTEX; KIDNEY GLOMERULUS; MALE; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0032745254     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00939.x     Document Type: Article

References (29)

1. Reichardt LF. Extracellular matrix molecules and their receptors. In: Kreis T, Vale R, eds. Guidebook to the Extracellular Matrix and Adhesion Proteins. Oxford University Press, Oxford, 1993.
2. Lin CQ, Bissell MJ. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 1993; 7: 737-743.
3. Gilbert RE, Cooper ME and Jerums G. Extracellular matrix, growth factors and their interactions in pathogenesis of diabetic kidney diseases. Nephrology 1996; 2: 291-303.
4. Border WA, Okuda S, Languino LR, Spore MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β. Nature 1990; 346: 371-374.
5. Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-β in kidney diseases. Am. J. Physiol. 1994; 35: 829-842.
6. Lovett DH, Johnson RJ, Mart HP, Martion J, Davies M, Courser WG. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex mediated glomerulonephritis. Am. J. Pathol. 1992; 141: 85-98.
7. Krakower CA, Greenspon SA. Localization of nephrotoxic antigen with the isolated renal glomerulus. Arch. Pathol. 1951; 51: 629-639.
8. Yagi M, Yamamoto T, Kato S, Nagano N, Kihara I. Long term observation of glomerulonephritis induced by multiple injections with anti-Thy-1 antibody in rats. Path. Int. 1998; 48: 491-498.
9. Chomczynski P, Sacchi N. Single -step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-159.
10. Tang WW, Feng L, Xia Y, Wilson CB. Extracellular matrix accumulation in immune-mediated tubulointerstitial injury. Kidney Int. 1994; 45: 1077-1084.
11. Xia Y, Garcia G, Chen S, Wilson CB, Feng L, Cloning of rat 92-KDa type IV collagenase and expression of an active recombinant catalytic domain. FEBS Lett. 1996; 382: 285-288.
12. Gilman M. Ribonuclease protection assay. In: Ausubel FA, Brent R, Kingston RE et al., eds. Current Protocols in Molecular Biology. Green Publishing and Wiley-Interscience, New York, 1991; 471-478
13. Schena FP, Gesualdo L, Grandaliano G, Montinaro V. Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int. 1997; 52: 1439-1457.
14. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. New Eng. J. Med. 1994; 10: 1286-1292.
15. Border WA, Nobel NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364.
16. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 1993; 92: 2597-2601.
17. Sporn MBV, Roberts AB. Transforming growth factor β: Multiple actions and potential clinical applications. J. Am. Med. Assoc. 1989; 262: 938-948.
18. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int. 1992; 41: 671-678.
19. Lelongt B, Trugnan G, Murphy G, Ronco PM. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J. Cell. Biol. 1997; 136: 1363-1373.
20. Schaefer L, Han X, August C, Matzkies F, Lorenz T, Schaefer RM. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats. Diabetologia 1997; 40: 1035-1043.
21. Sibley MH, Johnson JJ, Mello CC, Kramer JM. Genetic identification, sequence and alternative splicing of the Caenorhabditis elegans alpha 2 (IV) collagen gene. J. Cell. Biol. 1993; 123: 255-264.
22. Bohle A, Christ H, Grund KE, Mackensen A. The role of interstitium of the renal cortex in renal disease. Contrib. Nephrol. 1979; 16: 109-114.
23. Grandaliano G, Gesualdo L, Ranieri E et al. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides. A pathogenic role in interstitial monocyte recruitment. J. Am. Soc. Nephrol. 1996; 7: 906-913.
24. Pichler R, Giachelli CM, Lombardi D et al. Tubulointerstitial disease in glomerulonephritis: Potential role of Osteopontin (Uropontin). Am. J. Pathol. 1994; 144: 915-926.
25. Heeger P, Wolf G, Meyers C et al. Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int. 1992; 41: 220-225.
26. Okada H, Strutz F, Danoff TM, Kalluri R, Neilson EG. Possible mechanism of renal fibrosis. Contrib. Nephrol. 1996; 118: 147-154.
27. Okada H, Strutz F, Danoff TM, Neilson EG. Possible pathogenesis of renal fibrosis. Kidney Int. (Suppl.) 1996; 54: S37-S38.
28. Alpers CE, Picler R, Johnson RJ. Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int. (Suppl.) 1996; 54: S28-S31.
29. Strutz F, Okada H, Lo CW et al. Identification and characterization of a fibroblast marker: FSP1. J. Cell. Biol. 1995; 130: 393-405.